ARGA Investment Management LP Reduces Stake in Bath & Body Works, Inc. $BBWI

ARGA Investment Management LP lessened its position in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 12.0% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 545,534 shares of the company’s stock after selling 74,188 shares during the quarter. ARGA Investment Management LP’s holdings in Bath & Body Works were worth $10,185,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the company. Global Retirement Partners LLC purchased a new position in Bath & Body Works in the fourth quarter worth about $31,000. Activest Wealth Management bought a new position in shares of Bath & Body Works in the 4th quarter worth approximately $32,000. Geneos Wealth Management Inc. lifted its stake in shares of Bath & Body Works by 217.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after purchasing an additional 801 shares during the period. Parallel Advisors LLC lifted its stake in shares of Bath & Body Works by 42.6% in the 4th quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock worth $38,000 after purchasing an additional 567 shares during the period. Finally, Danske Bank A S purchased a new position in shares of Bath & Body Works in the third quarter worth approximately $39,000. Institutional investors own 95.14% of the company’s stock.

Bath & Body Works Price Performance

Shares of BBWI stock opened at $20.34 on Friday. Bath & Body Works, Inc. has a one year low of $14.27 and a one year high of $33.67. The company’s fifty day moving average price is $19.52 and its 200-day moving average price is $20.41. The company has a market capitalization of $4.10 billion, a price-to-earnings ratio of 5.71, a PEG ratio of 1.97 and a beta of 1.38.

Bath & Body Works (NYSE:BBWI) last issued its earnings results on Wednesday, May 27th. The company reported $0.32 earnings per share for the quarter, topping the consensus estimate of $0.29 by $0.03. The company had revenue of $1.38 billion during the quarter, compared to the consensus estimate of $1.36 billion. Bath & Body Works had a net margin of 10.03% and a negative return on equity of 45.34%. Bath & Body Works’s quarterly revenue was down 3.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.49 EPS. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Equities research analysts expect that Bath & Body Works, Inc. will post 2.63 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, June 19th. Investors of record on Friday, June 5th were issued a $0.20 dividend. The ex-dividend date of this dividend was Friday, June 5th. This represents a $0.80 dividend on an annualized basis and a yield of 3.9%. Bath & Body Works’s payout ratio is currently 22.47%.

Analyst Upgrades and Downgrades

BBWI has been the subject of several recent research reports. The Goldman Sachs Group lowered shares of Bath & Body Works from a “neutral” rating to a “sell” rating and cut their target price for the company from $23.00 to $19.00 in a research report on Wednesday. Raymond James Financial reiterated a “market perform” rating on shares of Bath & Body Works in a research report on Wednesday, May 27th. UBS Group dropped their price target on shares of Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 20th. Weiss Ratings raised shares of Bath & Body Works from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday. Finally, Piper Sandler began coverage on Bath & Body Works in a research note on Friday, May 15th. They issued a “neutral” rating and a $20.00 price objective for the company. Three equities research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $22.00.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.